SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-026609
Filing Date
2003-11-14
Accepted
2003-11-14 14:41:30
Documents
10
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-5156_110q.htm 10-Q 851781
3 EX-3.(I) a03-5156_1ex3di.htm EX-3.(I) 71015
4 EX-10.145 a03-5156_1ex10d145.htm EX-10.145 435594
5 EX-10.146 a03-5156_1ex10d146.htm EX-10.146 177995
6 EX-10.147 a03-5156_1ex10d147.htm EX-10.147 173606
7 EX-10.148 a03-5156_1ex10d148.htm EX-10.148 86187
8 EX-31.1 a03-5156_1ex31d1.htm EX-31.1 12998
9 EX-31.2 a03-5156_1ex31d2.htm EX-31.2 12307
10 EX-32.1 a03-5156_1ex32d1.htm EX-32.1 7742
11 EX-32.2 a03-5156_1ex32d2.htm EX-32.2 8609
  Complete submission text file 0001104659-03-026609.txt   1840379
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18006 | Film No.: 031003383
SIC: 2836 Biological Products, (No Diagnostic Substances)